Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Death with dipyridamole-thallium imaging

H Z Friedman, S F Goldberg, A M Hauser

    Annals of Internal Medicine
    |December 15, 1988
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patients with aortic stenosis referred for TAVI: treatment decision, in-hospital outcome and determinants of survival.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2011
    Same author

    Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?

    Heart (British Cardiac Society)·2009
    Same author

    Neuro-embolic protection during percutaneous balloon mitral valvuloplasty.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
    Same author

    Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.

    European heart journal·2003
    Same author

    Myocardial contrast echocardiography is superior to other known modalities for assessing myocardial reperfusion after acute myocardial infarction.

    Heart (British Cardiac Society)·2003
    Same author

    Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.

    Reviews in cardiovascular medicine·2002